Pregnancy and childbirth not only increase the risk for acquiring SARS-CoV-2 infection, but may worsen the clinical course of COVID-19. The number of new COVID-19 cases and deaths globally slightly decreased this week, with over 5.5 million cases and over 90,000 deaths. Case and death incidences, however, remain at the highest levels since the beginning of the pandemic. The choice to use a specific drug for COVID-19 in pregnancy should take into account. The drugs usually have benefits and possible adverse events in each single case. In this overview it will provide useful information for obstetricians for appropriate management for antenatal care in COVID-19. There are many challenges which mandate an integrated approach to pregnant woman’s who are affected by SARS-CoV-2. Here we present a case of asymptomatic COVID-19 in pregnant woman with non-classic diagnostic imaging modalities such as computed tomography findings and focused on medical management in this situation in order to prevent maternal and fetal complications in future. The medical management provided to COVID-19 positive during pregnancy and post-operative responded well to antibiotics such as azithromycin with mild computed tomography severity score recovered well soon.